Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duofilm is a topical keratolytic medication used for the treatment of common warts, plantar warts, corns, and calluses. It is a combination product containing salicylic acid and lactic acid in a flexible collodion base. Salicylic acid acts as a keratolytic agent by increasing skin hydration and dissolving the intercellular substance that causes skin cells to stick together, thereby facilitating the desquamation of the hyperkeratotic skin. Lactic acid serves to enhance the activity of salicylic acid and aids in the breakdown of the skin's keratin structure. The formulation is designed to dry into a thin, flexible film that maintains the active ingredients in contact with the affected area for an extended period. Originally developed by Stiefel Laboratories, the brand was later acquired by GSK and subsequently by STADA Pharmaceuticals in certain regions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salicylic acid + lactic acid.